CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, J.D., M.B.A., has been appointed President & Chief Executive Officer.
“It has been a pleasure working closely with Chris since he and I assumed leadership of Cerulean in October,” said Paul Friedman, M.D., Executive Chairman of Cerulean. “Chris has done an excellent job as Chief Operating Officer, and he was the obvious choice to take the reins. I am delighted to continue to work closely with him in my role as Executive Chairman.”
Help employers find you! Check out all the jobs and post your resume.
“It has been a pleasure working closely with Chris since he and I assumed leadership of Cerulean in October,” said Paul Friedman, M.D., Executive Chairman of Cerulean. “Chris has done an excellent job as Chief Operating Officer, and he was the obvious choice to take the reins. I am delighted to continue to work closely with him in my role as Executive Chairman.”
Help employers find you! Check out all the jobs and post your resume.